Laboratorios Farmaceuticos Rovi, S.A. (OTCPK:LABFF) 2024 Financial Results Earnings Conference Call February 25, 2025 4:00 AM ET
Company Participants
Javier López-Belmonte – Deputy Chairman and Chief Financial Officer
Juan López-Belmonte – Chairman and Chief Executive Officer
Marta Campos – Head-Finance
Conference Call Participants
Javier López-Belmonte
Good morning to everybody. Warm welcome to all those attending the presentation of Rovi’s 2024 Financial Results, which we will start in a moment. I’m Javier López-Belmonte, Rovi’s Deputy Chairman and Chief Financial Officer of the company. Joining me on today’s call are Juan López-Belmonte, Rovi’s Chairman and CEO; and Marta Campos, our Head of Finance. The presentation will be followed by a Q&A session. Therefore, if you want to ask any question during the presentation, please do not hesitate to send them through the question button on the platform.
Before we begin, let me remind you that the information presented in this call contains forward-looking statements based on our current beliefs and expectations. Actual results could materially differ due to a known and unknown risk, uncertainties and other factors and we undertake no obligation to update or revise any of the statements.
With that, I thank you for your presence here today and I will now hand the presentation over to Juan López-Belmonte. Please go ahead, Juan.
Juan López-Belmonte
Thank you, Javier, and good morning to everyone in the call. 2024 was a transition year for Rovi, crucial for establishing the basis for Rovi’s future. The company is currently undergoing a period where investment is essential to drive across and position the company for long-term success. In this context, our operating revenue decreased 7.9% as a result of lower revenues from the manufacture of the COVID-19 vaccine in comparison to 2023, when Rovi had booked higher income related to the production of the pandemic COVID-19 vaccine; and secondly because of lower revenues related to
#Laboratorios #Farmaceuticos #Rovi #S.A #LABFF #Financial #Results #Earnings #Call #Transcript